DNAVSLABT• 6 Months (Normalized)
DNA vs LABT (Ginkgo Bioworks Holdings Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Apr 1 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+54.05%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
LABT Performance $1.78
+%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+54.05 pts
DNA outperforming by 54.05 percentage points
DNALABT
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | DNA Price | DNA Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 28, 2026 | $10.46 | +54.05% | $- | - | |
| Sep 25, 2026 | $10.66 | +57.00% | $- | - | |
| Sep 24, 2026 | $10.25 | +50.96% | $- | - | |
| Sep 23, 2026 | $8.58 | +26.36% | $1.78 | -97.94% | +124.30% |
| Sep 22, 2026 | $9.37 | +38.00% | $1.99 | -97.70% | +135.70% |
| Sep 21, 2026 | $7.98 | +17.53% | $2.05 | -97.63% | +115.16% |
| Sep 18, 2026 | $7.88 | +16.05% | $1.99 | -97.70% | +113.75% |
| Sep 17, 2026 | $7.84 | +15.46% | $1.86 | -97.85% | +113.31% |
| Sep 16, 2026 | $7.06 | +3.98% | $2.09 | -97.58% | +101.56% |
| Sep 15, 2026 | $6.99 | +2.95% | $2.17 | -97.49% | +100.44% |
| Sep 14, 2026 | $7.01 | +3.24% | $2.12 | -97.55% | +100.79% |
| Sep 11, 2026 | $6.75 | -0.59% | $2.22 | -97.43% | +96.84% |
| Sep 10, 2026 | $6.78 | -0.15% | $2.05 | -97.63% | +97.48% |
| Sep 09, 2026 | $6.79 | +0.00% | $2.32 | -97.32% | +97.32% |
| Sep 08, 2026 | $6.94 | +2.21% | $2.18 | -97.48% | +99.69% |
Page 1 of 9